NextGen MURR is the University of Missouri’s transformational initiative to build a new 20-megawatt, state-of-the-art reactor. The new research reactor will expand critical medical isotope research and production for cancer treatments and theranostics. This project will build on the internationally recognized excellence of the 10 MW MU Research Reactor (MURR), the only U.S. producer of four medical isotopes used in lifesaving treatments for liver, thyroid, pancreatic and prostate cancer.

NextGen MURR will serve as an innovation and manufacturing hub for nuclear medicine in the United States for generations to come.

The University of Missouri is home to MURR, the world’s most important university research reactor for fighting cancer. Learn more about MURR, the importance of radioisotopes and how NextGen MURR will benefit Missourians and patients across the country and the world for decades to come.

As one of only six public universities in the country with schools or colleges of medicine, veterinary medicine, agriculture, engineering, arts and science, law and a powerful research reactor — all on one campus — Mizzou is uniquely positioned to tackle critical health challenges. With its campus partners, NextGen MURR supports the bench-to-bedside approach, bolstering the university’s role in the development of new treatments and scientific discoveries that save lives in Missouri, the U.S. and beyond.